MIRA Pharmaceuticals, Inc. Unrealized Gain (Loss) on Investments
MIRA Pharmaceuticals, Inc. (MIRA) reported Unrealized Gain (Loss) on Investments of -$87.55 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:UnrealizedGainLossOnInvestments · last filed 2026-08-12
- MIRA Pharmaceuticals, Inc. unrealized gain (loss) on investments for the quarter ending 2026-06-30 was -$87.55K.
- MIRA Pharmaceuticals, Inc. unrealized gain (loss) on investments for the quarter ending 2026-03-31 was -$91.58K.
- MIRA Pharmaceuticals, Inc. unrealized gain (loss) on investments for the quarter ending 2025-12-31 was -$211.27K.
- MIRA Pharmaceuticals, Inc. unrealized gain (loss) on investments for the quarter ending 2025-09-30 was $176.06K.
- MIRA Pharmaceuticals, Inc. unrealized gain (loss) on investments for fiscal 2025 was -$35.21K.
| Period end | Unrealized Gain (Loss) on Investments 3 month | Unrealized Gain (Loss) on Investments 6 month | Unrealized Gain (Loss) on Investments 9 month | Unrealized Gain (Loss) on Investments 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$87.55K 10-Q · filed 2026-08-12 | -$179.13K 10-Q · filed 2026-08-12 | -$390.39K derived: sum of 3 quarters · filed 2026-08-12 | -$214.34K derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | -$91.58K 10-Q · filed 2026-05-14 | -$302.85K derived: sum of 2 quarters · filed 2026-05-14 | -$126.79K derived: sum of 3 quarters · filed 2026-05-14 | |
| 2025-12-31 | -$211.27K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$35.21K derived: sum of 2 quarters · filed 2026-03-31 | -$35.21K 10-K · filed 2026-03-31 | |
| 2025-09-30 | $176.06K 10-Q · filed 2025-11-13 | $176.06K 10-Q · filed 2025-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B |